A Perfect Score For Héma-Québec's Montréal Centre

MONTREAL, QUEBEC, November 25, 1998 - Health Canada's Bureau of Biologics and Radiopharmaceuticals (BBR) issued no comments following an inspection of HÉMA-QUÉBEC'S blood collection and treatment centre in Montreal. This is the best possible score for a blood products manufacturer. The inspection, held on October 4, covered the period during which the Québec blood system was transferred from the Canadian Red Cross to HÉMA-QUÉBEC.

HÉMA-QUÉBEC Executive Director, Dr. Francine Décary, was very pleased with the inspection results: "This demonstrates the efforts of our employees to perform quality work and follow to the letter the procedures set out in our operating license."

All producers of blood products are subject to inspection. The BBR regularly inspects collection and treatment facilities to ensure that their activities comply with national requirements. The BBR may provide written comments on a facility's procedures, in which case the facility must provide a written reply within a certain period explaining what it plans to do in response to the comments.

BBR teams inspect the blood collection and treatment centers operated by HÉMA-QUÉBEC in Québec and Canadian Blood Services elsewhere in Canada, enabling the Bureau to make suggestions based on the best practices in place in Canada.

HÉMA-QUÉBEC's mission includes providing Quebeckers with adequate quantities of superior-quality and safe blood components, derivatives, and substitutes to meet the needs of hospitals, and to provide recognized expertise and services in immuno-hematology.

NOTE: Copies of the BBR report are available upon request.